AllegisCyber Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Syntaxbiosyntaxbio.cominSeries A · Jun 2026 · $14M
Syntax Bio operates a stem cell discovery platform that uses its Cellgorithm technology to directly control and accelerate cell differentiation into a range of functional cell types.
BiotechDeep Tech
Co-investorsDCVC (Data Collective)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.